Business Context and Reporting Period
This Form 8-K Current Report was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on December 18, 2024, regarding events occurring on December 16, 2024. The company is incorporated in Delaware and trades on the NASDAQ under the symbols ATNF (Common Stock) and ATNFW (Warrants).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Departure of CFO: Mr. Omar Jimenez, the Chief Financial Officer and Secretary, tendered his resignation effective immediately on December 16, 2024.
- Reason for Departure: The resignation was not the result of a disagreement with the Company regarding operations, policies, or practices.
- Interim Appointment: Blair Jordan, the current Interim Chief Executive Officer, assumed the role of principal financial/accounting officer on an interim basis effective December 16, 2024.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of market risks. Regarding the leadership transition:
- Mr. Jordan will not receive additional compensation for assuming the interim principal financial officer responsibilities.
- There are no undisclosed arrangements or related person transactions requiring disclosure under Regulation S-K.
Investor Verification Checklist
- Verify the ticker symbol discrepancy: The filing is for 180 Life Sciences Corp. (ATNF), not Forum Markets Inc.
- Confirm the timeline for the appointment of a permanent Chief Financial Officer.
- Review the Company's proxy statement filed on November 12, 2024, for biographical details on Blair Jordan.
- Monitor future filings for any financial restatements or disclosures related to the CFO's tenure.